Skip to main content
Premium Trial:

Request an Annual Quote

Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy

NEW YORK – Personal Genome Diagnostics said Tuesday that it has partnered with the Center for Immunotherapy and Precision Immuno-Oncology and the Cleveland Clinic Lerner Research Institute, with plans to enhance PGDx's Elio plasma complete test reports and develop new liquid biopsy methods and assay iterations.

The effort is being led by Jame Abraham, interim chair of the Cleveland Clinic Taussig Cancer Institute, and Brian Rubin, chairman of the clinic's Pathology and Laboratory Medicine Institute.

In a statement, Timothy Chan, chair of Cleveland Clinic’s Center for Immunotherapy and Precision Immuno-Oncology, said the collaboration will allow the institutes to explore new options to improve treatment strategies and patient outcomes in cancer.

"By investing in comprehensive testing solutions that utilize noninvasive sampling techniques, we intend to explore the clinical utility of high impact biomarkers such as blood TMB, clonal hematopoiesis, and others, with the aim to improve therapeutic modalities for human cancers," he said.

"We look forward to expanding upon the capabilities of Elio plasma complete and paving the way for a center of excellence enabling enhanced testing of ctDNA in cancer," PGDx CEO Megan Bailey added.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.